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Abstract
Background: People living with diabetes can reduce their risk of vision loss from diabetic retinopathy by attending
screening, which enables early detection and timely treatment. The aim of this pilot trial was to assess the feasibility
of a full-scale cluster randomized controlled trial of an intervention to increase uptake of retinal examination in this
population, as delivered within existing community-based diabetes support groups (DSGs).
Methods: All 16 DSGs in Kirinyaga county were invited to participate in the study. The first two groups recruited
took part in the pilot trial. DSG members who met the eligibility criteria were recruited before the groups that were
randomized to the two arms. In the intervention group, two peer educators were trained to deliver monthly DSG-
based eye health education and individual telephone reminders to attend screening. The control group continued
with usual DSG practice which is monthly meetings without eye health education. The recruitment team and
outcome assessors were masked to the allocation. We documented the study processes to ascertain the feasibility,
acceptability, and potential effectiveness of the intervention. Feasibility was assessed in terms of clarity of study
procedures, recruitment and retention rates, level of acceptability, and rates of uptake of eye examination. We set
the target feasibility criteria for continuation to the main study to be recruitment of 50 participants in the trial, 80%
monthly follow-up rates for individuals, and no attrition of clusters.
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Results: Of the 122 DSG members who were assessed for eligibility, 104 were recruited and followed up: 51
(intervention) and 53 (control) arm. The study procedures were well understood and easy to apply. We learnt the
DSG meeting days were the best opportunities for recruitment. The study had a high acceptance rate (100% for
clusters, 95% for participants) and high follow-up and retention rate (100% of those recruited). All clusters and
participants were analysed. We observed that the rate of incidence of eye exam was about 6 times higher in the
intervention arm as compared to the control arm. No adverse unexpected events were reported in either arm.
Conclusions: The study is feasible and acceptable in the study population. The results support the development of
a full-scale cluster RCT, as the success criteria for the pilot were met.
Trial registration: Pan African Clinical Trials Registry PACTR201707002430195 Registered on 25 July 2017.
Keywords: Diabetes, Diabetic retinopathy, Peer support, Kenya, Pilot, Cluster randomised controlled trial
Background
The long-term complications of diabetes, such as diabetic
retinopathy (DR), are a threat to health among people liv-
ing with diabetes (PLWD). DR is a growing concern in
global health epidemiology due to the high proportion of
DR that remains undetected. Vision loss from DR can be
prevented through regular retinal screening (hereafter re-
ferred to as “screening”) and timely treatment [1–3]
There is notable geographic variation in the incidence
and visual impairment burden of DR, both within and be-
tween countries, reflecting variation in access to health
care [4–8]. Services for DR prioritize early detection,
metabolic control, regular monitoring, and timely treat-
ment. Access to these services is a significant challenge
due to demand side barriers (such as low awareness of
the need for services among PLWD) and supply side bar-
riers (such as availability of clinical guidelines or screen-
ing services) [9]. There is need for better evidence and
patient empowerment to address the demand side bar-
riers, as well as health system strengthening to address
supply-side barriers [9–11].
In the Global action plan for the prevention and con-
trol on non-communicable diseases (NCDs) 2013–2020,
the World Health Organization (WHO) highlighted the
need to empower people with NCDs to seek early detec-
tion, and to provide them with appropriate education,
incentives, and tools for self-management [12]. The peer
support model has been used in diabetes and other
chronic conditions to improve social support and self-
management, with positive outcomes in other countries
[13–17]. Traditionally, peer support model has not been
used in diabetes eye health services and subsequently,
there is a knowledge gap regarding its effectiveness to
reduce vision loss from diabetic retinopathy. Leveraging
on peer support in a clinical or community setting might
be a potential enabler for the adoption of healthy behav-
iours, such as screening.
Clinical guidelines for the management of DR target
were to have a 100% attendance of PLWD at annual
screening [18]. Our research group has previously
reported that PLWD in three counties of Kenya have
low attendance to annual screening, which is the fre-
quency recommended in this setting [19]. This is con-
sistent with findings that uptake of DR screening is low
in many parts of the world, but more so where access to
health care is generally limited [9]. To address this def-
icit, the Uptake of Retinal Examination in Diabetes
(DURE) trial [20] aims to test the effectiveness of peer
support in increasing the uptake of retinal examination
among members of diabetes support groups (DSGs).
Diabetes support groups are volunteer social groups of
PLWD in which peers provide mutual support for im-
proving diabetes care. The support may include informa-
tion and skills for self-management, as well as emotional
support. Given this objective, DSG members are likely to
be health conscious and interested in adopting healthy
behaviours. This intervention in this study is based on
the self-efficacy theory [21] and is targeted to PLWD
who are already members of support groups and have
not had screening in the previous 12months or longer.
Screening in this setting involves a visual acuity test and
a retinal examination through a dilated pupil [18, 22].
The study setting is a rural county whose inhabitants
are mainly small scale farmers. The DSGs are spread
over the 1200 km2 area of the county. Undertaking the
DURE study raises important practical concerns. In this
pilot study, our aim was to gain experience in delivering
the intervention and to assess if the DURE cluster ran-
domized clinical trial (cRCT) is feasible by (1) testing
clarity and ease of study procedures for enrolment and
data collection, (2) determining the potential for partici-
pant recruitment and retention, (3) assessing the accept-
ability of the intervention, by considering the level of
adoption of the study interventions by different actors,
and (4) documenting an interim measure of the effect-
iveness of the intervention on the uptake of screening.
Our hypothesis was that it is feasible to conduct the
DURE study. We set the target feasibility criteria for
continuation to the main study to be recruitment of 50
participants in each cluster, at least 80% follow-up rate
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of participants in each month of the trial and no attri-
tion of clusters. The 90-day duration of the pilot trial
was considered sufficient for these feasibility objectives,
while the main trial will take 6 months.
Methods
Study setting
The demographic and health statistics of Kirinyaga
county are highlighted in Table 1. The study interven-
tion was developed following a health system assessment
for diabetes and diabetic retinopathy in three counties of
Kenya [23] conducted by our research team, which iden-
tified gaps in access to services for DR, as well as the
need for health system strengthening. We found that
only 7% of PLWD in this county had a DR screening
exam in the preceding 12months. The main barriers to
access are lack of referral from diabetes services, lack of
knowledge of diabetes eye complications among PLWD,
and the belief that a screening exam is only necessary
once ocular symptoms develop.
An estimated 25–30% of the PLWD in the county are
regular members of DSGs (with a registration number)
while another 20% of PLWD attend some DSG meetings
even though they are not members. Members are re-
cruited by peer group leaders and community health vol-
unteers as they give group health talks at community
meetings, churches, outreach camps, and diabetes clinics
in health facilities. As membership is entirely voluntary,
the distribution of members by demographic parameters
in different groups varies. All groups are under the
Kenya Defeat Diabetes Association, which provides them
with equipment for use within the group (such as a gluc-
ometer and a blood pressure machines). The association
also trains peer supporters and DSG leaders.
DSGs hold routine monthly meetings at a dedicated
time and location in the community. Eighty percent of
the members attend at least two thirds of the meetings
annually. The meetings are held in the morning, starting
between 8 and 9 am and last 2–3 h. Each member’s fast-
ing blood sugar, blood pressure, and weight are re-
corded. The group then shares a light meal. The cost of
the blood sugar test strips and meal is met by a contri-
bution of Kenya shillings 100 (the equivalent of 1$
dollar) per PLWD attending the meeting. The other ac-
tivities in the meeting include group health talks deliv-
ered by peer supporters, informal discussions among
PLWD, planning for advocacy, and awareness-raising ac-
tivities. Record of these activities is captured in attend-
ance registers and minutes of the meeting.
Sample
All 16 DSGs in Kirinyaga were eligible for inclusion. We
invited the DSG leaders to a meeting where we ex-
plained the objectives of the DURE study and invited all
the groups to participate. The leaders then took time to
discuss the study with their members before giving ap-
proval through signing consent forms. The first two
DSGs to confirm willingness to participate were in-
cluded in the pilot study, for simplicity, transparency,
and visibility to the DSG leaders. All sixteen DSGs con-
sented to participate; hence, the remaining 14 will par-
ticipate in the main study.
We aimed to recruit at least 50 members who met the
eligibility criteria (Table 2) in each DSG (average size of
DSGs is 100 members). This is the same cluster size
Table 1 Demographic and health statistics—Kirinyaga county
Parameter Kirinyaga county Kenya
Total population (estimates based
on 2009 census) [24]
595,379 48.5million
Females 50% 50%
Age > 18 years 409,995 22,005,235
Urban population 16% 29.9%
No of people with diabetes (2%) [25] 8,185 440,104
No of people needing an annual
eye exam
8,185 440,104
No of eye care facilities 1 112
No of ophthalmologists 1 115
No of ophthalmic clinical officers 3 300
No of ophthalmic nurses 0 200
Table 2 Eligibility criteria
Eligibility criteria for participants Eligibility criteria for peer supporters
Inclusion criteria Inclusion criteria
Age > 18 years Age > 18 years
Member of a diabetes
support group
Member of a diabetes
support group
Will reside in the county
for the next 12 months
Will reside in the county
for the next 12 months
Has a mobile phone Has a mobile phone
Willing to participate in
the study
Willing to participate in
the study
Has not had a screening
exam in the last 12 months
Willing to be a peer educator
Willing to commit 2 days
for training
Willing to commit many
hours to peer support work
Fluent in Kikuyu or Kiswahili
Has had a screening exam
in the preceding 12 months
Exclusion criteria Exclusion criteria
Already attending DR
screening
On treatment for DR
On treatment for DR Has a debilitating illness
Has a debilitating illness
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calculated for the main study, using formula for sample
size calculation in cRCTs, provided by Hayes and Ben-
nett [26]. A statistician not involved with the fieldwork
conducted the sample size calculation. We also recruited
two peer supporters (1 male and 1 female) who met the
eligibility criteria to deliver the intervention in the inter-
vention cluster.
Design
The pilot study design mimics the design of the main
study, being a two arm cRCT with a 1:1 ratio. A research
nurse who is a local health worker recruited participants
who met the eligibility criteria during a DSG meeting.
The list of existing DSG members was provided by the
DSG lead. Verbal consent for recruitment and follow-up
was obtained from individual participants. Baseline
demographic, anthropometric, and metabolic data was
collected at the time of recruitment. All participants
were given a study identifier card to present at the eye
clinic at the time of eye exam.
Two members of the research team observed the re-
cruitment process to identify any difficulties with partici-
pant recruitment, eligibility criteria, or completing the
data collection tool. The recruitment nurse provided
additional feedback on these critical components in a
debriefing session after each recruitment session.
Following participant recruitment within each of the
DSGs, random allocation of the intervention was
through drawing of lots. A lay person not participating
in the study picked one of four sealed and opaque enve-
lopes from a container, in the presence of two members
of the research team. Each envelope contained a card
bearing the name of one DSG and either “intervention”
or “control.” Opening the envelope revealed the arm al-
location for one group, and by inference, the allocation
of the other group. This allocation was copied on the en-
velope and stored to provide a reference trail. The
remaining envelopes were destroyed. The participants in
each group were followed up by a research assistant (not
involved in recruitment or outcome assessment) at
monthly intervals for 90 days from the first group educa-
tion session, to check retention rates.
The feasibility outcomes were the achievability of recruit-
ing 50 participants in each cluster and the viability of at
least 80% follow-up rate of participants in each month of
the trial. The records at Kerugoya County Hospital eye
clinic were monitored daily, and the identifier cards of par-
ticipants that attended screening were deposited in a spe-
cific container by the eye care team. These cards were then
collected and given to the outcome assessment nurse (not
involved in recruitment or follow-up). During the study, we
also found that some eye care teams external to the county
health services held outreach camps in the county and pro-
vided screening for some of the participants. As our team
was alerted ahead of the outreach camps, we liaised with
these teams and monitored the attendance of any study
participants. As they used the same screening guidelines,
any participants screened at the outreach site were taken to
have the outcome of interest.
The recruitment nurse, research assistants, and the
outcome assessors had no training in eye care and were
masked to the cluster and participant allocation, to avoid
contamination and bias. The eye care providers were
also masked to the intervention allocation. It was not
possible to mask the study participants or peer educators
in the intervention arm, because the peer educators’ ac-
tivities within the DSG were overt. As attendance to
screening was assessed from hospital records, we con-
cluded that the lack of masking could not incentivise
over-reporting or under-reporting in either arm.
Intervention
The DSG in the intervention arm received the study
intervention combined with usual care for 90 days, while
the control group received the usual standard of care
alone (Table 3). The intervention was a monthly group
health talk and individual monthly telephone reminders
to attend eye exam, delivered by two peer educators (1
male, 1 female) collaboratively. The intended mechanism
of the intervention and the key messages to be delivered
in the health talk are described in the trial protocol [20].
Fidelity to the intervention and the influence of peer
supporter characteristics will be assessed in the process
evaluation of the main trial.
We trained the peer educators for 2 days to deliver the
intervention. They had already received previous training
as peer educators (training provided by the Kenya Defeat
Diabetes Association) and had about 4 years of experi-
ence with providing peer education. We also supported
them during the implementation phase in the following
ways: (1) Telephone calls were made by the team before
and after each group session to discuss the sessions and
any challenges faced by the peer leaders. (2) Practical
support was provided to help organize the logistics for
local program delivery, such as provision of telephone
airtime and reimbursement for transport costs for peer
educators. (3) The research team attended two of the
three DSG meetings. Peer educators kept logs of the
DSG attendance during group sessions and the individ-
ual reminders.
Reporting and analysis
This study is reported in accordance with the Consoli-
dated Standards of Reporting Trials (CONSORT) guide-
lines for pilot studies [27]. The CONSORT flow chart
(Fig. 1) and the checklist ire included. We documented
recruitment procedures and rates, reasons for ineligibil-
ity and non-participation, and follow-up rates. We
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calculated descriptive statistics for each study arm at
baseline. We also summarized survival outcomes at arm
level as per intention-to-treat analysis and estimated
hazard ratio for any differences. All data analysis was
carried out using Stata (version 15).
Results
The results are reported under four headings corre-
sponding to the specific objectives of the pilot trial.
Study procedures for enrolment and data collection
We found that the enrolment rate was high during the
DSG meetings. The peer group leaders could predict
which meetings would be well-attended, considering
other concurrent community activities, and they also
mobilised members to attend. We found it helpful to li-
aise with these leaders in planning for the recruitment.
The study materials were easy to carry around and
work with. We did not identify any practical, ethical, or
interpretation difficulties in the use of the eligibility cri-
teria and the completion of the data collection tools.
Thus, the eligibility criteria were found to be appropri-
ate, and the data collection tools were well understood.
We collected baseline data for all participants, before
randomization.
The time taken to complete the data collection pro-
cesses per participant exceeded the planned time. Some
of the participants had difficulty finding some of the data
that we needed for the purpose of follow-up, such as the
telephone numbers of the next of kin, but with assist-
ance, they were able to retrieve this from their phones
or to contact other people who had the data. However,
this added about 10 min per participant over the initial
estimates for the recruitment process. This resulted in
increased waiting time for the other persons awaiting
recruitment. Learning from this, we trained three add-
itional research nurses for the recruitment team, so that
at least two of them could attend each recruitment
meeting.
The data collection tools were checked for complete-
ness at the recruitment site by a research assistant. All
the data forms were also checked by the team lead for
quality assurance after each recruitment meeting. There-
after, the forms were sent to the data entry assistant
where further quality checks were carried out as data
was entered into a database.
We used standardised protocols for all measurements,
and the descriptive data is provided in Table 4. The two
arms were balanced for most characteristics except age and
gender. Females and older people were over-represented in
the intervention arm. This difference reflects the variation
in the existing composition of the DSGs.
Potential for recruitment and retention
The response rate of clusters was good (both accepted
to participate). All 122 participants assessed for eligibility
were willing to participate, but 6 (4.9%) withdrew during
the recruitment process because of long waiting time. Of
the 122 assessed for eligibility, 12 (9.8%) were ineligible
as they were temporary visitors (non-resident) or were
going to be absent from support groups during the study
period (school and employment commitments).
By conducting recruitment at well-attended routine
DSG meetings, all or most of the regular DSG members
had an equal chance to be recruited in the study. We
were able to recruit within the anticipated time such
that all the participants entered the study at time 0,
and we had similar recruitment levels in both clus-
ters. Follow-up rates were high in both arms. Both
DSGs remained in the study and received the
intended intervention (Fig. 1). One peer educator fell
sick over part of the period, but by this time most of
participants in the intervention arm already had the
outcome of interest, the other peer supporter was
able to carry on with the intervention. All participants
were followed up for 90 days, and there was 0 loss to
follow-up.
Table 3 Trial Interventions
Domain Intervention group Control group
Usual care Monthly group meetings with general diabetes education talks,
blood sugar, and blood pressure measurements
Monthly group meetings with general diabetes
education talks, blood sugar, and blood pressure
measurements
Intervention
Peer supporters training Two days training following a structured curriculum regarding
diabetes eye disease, retinal screening, role of peer supporters,
communication, and other aspects specified in the protocol [20]
Group education Monthly group education provided by trained peer supporters,
with structured content on diabetic eye disease and retinal
screening as specified in the protocol [20]
Individual participant
reminders
Monthly individual telephone reminder by peer supporters
to participants to take a screening exam as specified in the
protocol [20]
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Acceptability of the intervention
Before the start of the study, we had initial meetings
with the Ophthalmic Services Unit at the national level,
the Kirinyaga county director of health services, eye care
providers in the county, and the national officials of
Kenya Defeat Diabetes Association (KDDA) which is the
umbrella body for DSGs. We obtained their buy-in for
the study, and they linked us with the DSGs.
Given the recruitment rates, the follow-up rates and the
attrition rates (Fig 1), the study, and the intervention were
acceptable to participants and clusters. The peer supporters
attended all the sessions of the 2-day training and gave the
group talks as planned. For the individual telephone re-
minders, we found that peer educators supplemented this
with face-to-face discussions with the individuals who were
yet to take a retinal exam (in addition to the telephone re-
minders). This flexibility reflects a sense of ownership of
the intervention by the peer educators.
We did not record any adverse event related to the
intervention. Temporary blurring of vision after dilatation
of the pupils during retinal examination (the outcome of
interest) is a common undesirable effect but this was ex-
plained to the participants before examination, and none
of them declined to have the examination.
Fig. 1 Flow diagram for the pilot study
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The “drop-in” referral mode of patients from the DSGs
for screening for DR was acceptable to both patients
(who adopted it) and eye care providers (as they
screened all who dropped in). The attendance to the eye
clinic showed some peaks, and during these peaks, the
workload in the eye clinic was significantly increased;
however, all who turned up were screened. None of the
participants who presented at the eye clinic had lost or
forgotten the identifier card, which would suggest that
the card was highly valued. Such participants would still
have received screening even without the cards, and this
would be captured in the eye clinic records.
Estimating the potential effectiveness of intervention
We estimated the tentative effectiveness of the interven-
tion in both arms, although the study was not powered
for hypothesis testing. Participation rates are presented
without adjustment for clustering.
The intervention arm had a substantially higher uptake
of eye exam during the trial (Fig. 2). Of the 104 partici-
pants, 31(29.8%) attended screening during the trial: 25/
51 (49%) in the intervention arm, as compared to 6/53
(11.3%) in the control arm.
In the intervention arm, the rate at which participants
attended an eye exam was high immediately after the
start of the intervention, and then it decreased (Fig. 2).
The highest rates were observed between day 10 and 20
following the first group education session, even though
the education sessions continued on a monthly basis.
The pattern suggests that most of the benefit of the
intervention occurs early in the intervention. In the con-
trol arm, the rate of eye exam was nearly constant. Even
though it increased around day 50 (without any inter-
vention), it did not reach the rate in the intervention
group.
Discussion
We are the first to report a pilot cluster RCT on the
feasibility of a full-scale RCT to assess the effectiveness
of a community-based DSG intervention to increase up-
take of screening among PLWD. Other studies have ex-
amined the effectiveness of such community-based
groups on health outcomes such as maternal, neonatal,
and childhood survival [28–31].
The study has several strengths. Firstly, a mixed
methods health system assessment [23] preceded the
trial. This helped to identify DSGs as a community re-
source that was a potential channel for increasing uptake
of screening. Secondly, this study targets PLWD in a
rural setting who have not had screening in the last 12
months. However, we found that our participants had
never had screening, which means that the people who
are the most vulnerable to DR-related blindness and
who need the intervention most were included. It is
known that screening programs are more cost-effective
in people who derive more benefit from screening [2, 7].
Table 4 Baseline characteristics
Intervention (N = 51) Control (N = 54) Total (N = 104)
Age (years)
Mean (SD); Median (IQR) 66.4 (10.8); 69(60-72) 58.2 (11.8); 57(57-62) 62.2 (12); 63(54.5-70)
Sex
Female (%) 41 (80.4) 30 (56.6) 71 (68.3)
Duration of diabetes (years)
Median(IQR) 5.0 (2–10) 5.0 (2–8) 5.0 (2–10)
Duration of support group membership (years)
Median (IQR) 3.0 (1–3.5) 2.0 (1–4) 2.0 (1–4)
Anthropometric measures
Body mass index (kg/m2)
Male 25.0 (2) 25.3 (4.4) 25.2 (3.8)
Female 25.4 (3.9) 26.4 (3.4) 25.8 (3.7)
Waist circumference (cm)
Male 96.5 (7.3) 96.0 (11.1) 96.1 (10)
Female 97.0 (8.9) 100.0 (8.4) 98.3 (8.8)
Metabolic measures
Fasting blood sugar ( g/dl) 7.4 (2.7) 9.1 (4.5) 8.3 (3.8)
Systolic blood pressure (mmHg) 139.0 (20) 142.0 (26) 141.0 (23)
Diastolic blood pressure (mmHg) 81.0 (7.6) 78.0 (13) 80.0 (11)
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Thirdly, it is known that demand-side behaviour
changes alone may be insufficient to change the health
outcomes being addressed; therefore, health system
strengthening is important before or within a trial [28,
29, 32]. Before this study, we developed and imple-
mented national clinical guidelines for DR, and our
training program for peer supporters is currently being
embedded in the Kenya Defeat Diabetes Association
peer support manual. Therefore, a further strength of
the study is that we tested the intervention within a big-
ger health system strengthening context [33, 34]. Fourth,
the study setting, eligibility criteria, study design, and
amount of data collected in the pilot are by design, simi-
lar to what will be collected in the main study. This
makes it easy to transfer the learning from the pilot to
the main study.
Our findings show that the potential for recruitment
and the feasibility of data collection, study implementa-
tion, and follow-up is high. There was high acceptability
of the study in general and the intervention in particular,
by the participants. This might be because the DSG
members are already health conscious, or because of the
community entry process that we followed. The top lead-
ership of KDDA and the county director of health services
introduced us to the county support group leader, who in
turn introduced us to the DSGs. We had strong liaison
with these stakeholders and with local health care
workers which helped successful study implementation.
We considered this to be important because the feasibil-
ity of the implementation and future scalability of the
intervention depend on acceptability not only among the
participants but also among these stakeholders in health
care [35]. Further, the intervention itself also requires
constant engagement with the DSGs and the participants,
which may have aided the acceptability and retention of
participants in the study. Of note, we did not pay the par-
ticipants, they participated voluntarily.
The recruitment process was embedded in DSG meet-
ings, which was a critical factor for efficiency in recruit-
ment. We learnt that recruitment required more time
and more research nurses than initially planned, and this
will be taken into account in the main study. The pilot
findings suggest that the trial should achieve high re-
cruitment and retention. We excluded PLWD who were
temporary visitors to the DSGs, as they were not likely
to stay long enough to receive the intervention. Other
studies have used a similar approach to avoid contamin-
ation between clusters [34]. We monitored support
groups’ attendance and did not have evidence of inter-
cluster migration in our study. We also learnt the neces-
sity of liaison with mobile eye care providers from other
counties who visit Kirinyaga county on eye camps, as
they provided screening to this population (besides the
static eye clinic at Kerugoya county referral hospital).
When interventions are implemented in real-world
settings, some degree of flexible adaptation of program
components occurs [35–37]. Although mobile phone in-
terventions are useful due to their ubiquity even in this
population [38], we found that face-to-face contact is
valued, and that peer educators still supplemented indi-
vidual telephone reminders (prescribed in the protocol)
with additional face-to-face reminders to persons who
had not yet taken a retinal examination. This is perhaps
because of the close residential proximity of the mem-
bers and the existing personal relationships between
them. It also reflects that in the “real world” setting, peer
Fig. 2 Kaplan-Meier analysis of the time from the first education session to attendance at the retinal screening (days)
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support is not provided in tightly sequential or discrete
categories. These flexible interactions may have contrib-
uted to the success of the intervention. The peer sup-
porters in this study were highly experienced with peer
support, having been peer supporters for a long time
and having had other trainings. This may have contrib-
uted to the success of the study, and it is not known
whether if we have less experienced peer supporters in
the main study, we would have different findings.
In the pilot study, we observed a much greater propor-
tion of individuals attending retinal screenings in the
intervention arm than in the control arm. Given only one
cluster was randomised to each arm, we cannot draw in-
ferences from this, but it does suggest that the interven-
tion has potential and is worth bringing forward to the full
trial. Among those in the intervention arm who had eye
exam, there was a striking uptake of the exam in the first
two weeks of the intervention. This means the benefit of
the intervention was visible within a short period. Con-
versely, it also means that there is risk of eye care provider
fatigue if the same pattern of uptake is seen in the larger
full trial. Kwaku et al. [32] have noted that such negative
effects can be experienced in a clinical trial. We did not
experience this in the pilot. In the full trial, we will stagger
the intervention over time; hence, this challenge is un-
likely to occur. As most of the PLWD only need one
screening examination annually, we do not expect this to
be a significant problem beyond the study.
Although the participants were aware of the risk of
temporary blurring of vision during dilated eye exam,
this was not a barrier to uptake of eye exam. However,
since this is the first screening examination for the par-
ticipants, we do not know whether it would be a barrier
to future screening.
It is a good practice to consider the attributes that
contribute to the scalability of interventions, even at the
stage of pilot trials [39]. This pilot trial represents a step
towards developing a scalable intervention because of its
acceptability to participants. Acceptance by PLWD is ne-
cessary but not sufficient for scalability, since it also
needs the support of service providers, administrators,
and policy-makers. Based on the evidence from the pilot
trial, scalability might also be feasible because of (1) the
acceptability and involvement of state and non-state
stakeholders who run the support groups and health ser-
vices, (2) the trial is implemented within routine (prag-
matic) conditions, and (3) we documented the processes
involved in the trial.
The pilot study had some limitations. We only in-
volved two DSGS in the study (out of the 16 DSGs in
the county) but we considered this to be sufficient to ad-
dress the issues of uncertainty in the feasibility of the
study. For the main trial, we have recruited the other
fourteen support groups (seven in each arm).
The first two DSGs that accepted to participate in the
study were recruited in the pilot study. This convenience
sample might mean that these initial findings are not
generalizable to all DSGs. However, we considered that
this method is helpful to demonstrate transparency to
the DSG leaders and to meet the feasibility objectives.
As women and older people were over-represented in
the intervention arm, the extent to which the interim re-
sults of the effectiveness of the intervention can be ex-
tended to men is not clear. With the larger sample size
of the main trial (700 participants), we expect more bal-
ance, but if this is not the case, we will conduct sub-
group analysis.
Given that this is pragmatic trial [20], we anticipate that
co-interventions may occur in the “real-world” setting of
the study. We found that there were external outreach eye
camps in the county during the trial period. These camps
have the potential to introduce co-intervention bias, par-
ticularly if they include eye health promotion activities.
However, the exposure to this co-intervention was likely
balanced between the two arms, since the camps were
widely publicised through community meetings and held
at diverse locations across the county. In the main trial,
we will identify any pre-specified or unplanned co-
interventions, assess the risk of co-intervention bias, and
estimate its effect on the trial outcomes.
We did not perform a process evaluation at this stage;
however, this is planned as part of the main study [20],
when we will have data on the primary and secondary out-
comes. The process evaluation will help us understand the
way the intervention worked to lead to these outcomes.
Conclusion
The pilot study met our success criteria for the feasibility
objectives. We conclude that a full trial of the intervention
is feasible, and the results of this pilot will inform this full
trial. The findings of this study may be relevant to other
countries with a similar model of DSGs. Given the paucity
of literature on implementing community-based interven-
tions, the results of this pilot may be of interest to other
researchers interested in addressing feasibility challenges
in cRCT interventions targeting community groups.
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